Claim
The structural foundations of anti-amyloid-β immunotherapies: Unravelling antibody-antigen interactions in Alzheimer's disease treatment.
Miles LA et al. 2025, Journal of Alzheimer's disease : JAD
Evidence span
The structural foundations of anti-amyloid-β immunotherapies: Unravelling antibody-antigen interactions in Alzheimer's disease treatment.
From Miles LA et al. 2025, Journal of Alzheimer's disease : JAD
Method & conditions
- Evidence type
- experimental
- Method
- manual state transition; placebo-controlled clinical trial where source reports control arm
- Species
- Homo sapiens
- Conditions
- Humans; Alzheimer Disease; Antibodies, Monoclonal; Immunotherapy; Structure-Activity Relationship — Journal of Alzheimer's disease : JAD 2025
- Replicated
- not yet
Confidence basis
operator-supplied frontier prior; review required